News | Wearables | December 07, 2022

University of Missouri Researchers Design New Heart Health Wearable

Using a $2.6 million grant from NIH, researchers at the MU College of Engineering are designing a breathable material with antimicrobial properties for use with a wearable heart monitor. 

Brian Arends, left, checks the electrical resistivity and conductivity of the wearable heart monitor as Zheng Yan, center, and Yadong Xu, right, observe in Yan's lab. The lab is located in the Roy Blunt NextGen Precision Health building. Pate McCuien/University of Missouri

Brian Arends, left, checks the electrical resistivity and conductivity of the wearable heart monitor as Zheng Yan, center, and Yadong Xu, right, observe in Yan's lab. The lab is located in the Roy Blunt NextGen Precision Health building. Pate McCuien/University of Missouri 

 


December 7, 2022 —  While heart disease is a leading cause of death in the United States, most people can be treated with early detection and timely interventions. That’s why Zheng Yan and a team of researchers at the University of Missouri are using a $2.6 million grant from the National Institutes of Health (NIH) to help create a breathable material — with antibacterial and antiviral properties — to support the team’s ongoing development of a multifunctional, wearable heart monitor. 

The wearable device is designed to continuously track the health of a human heart via dual signals simultaneously — an electrocardiogram (ECG), which measures a heart’s electrical signal, and a seismocardiogram (SCG), which measures heart vibrations. After these signals are recorded on an electronic device, this information could be shared with a person’s healthcare provider to help identify potential warning signs related to heart disease. 

Yan, an assistant professor in the Department of Biomedical, Biological and Chemical Engineering and the Department of Mechanical and Aerospace Engineering, said the device is designed for use in personalized health care. 

“We want to provide comprehensive information about the status of a person’s heart,” Yan said. “Effects of heart disease can often happen unexpectedly, so it’s important to have continuous, long-term monitoring for early detection and timely interventions. We want this to help reduce the number of people succumbing to death from heart disease in the U.S.” 

Since the breathable material encompasses the device and may potentially stay attached to a person’s skin for at least a couple weeks, or even up to one month, Yan said the material’s integrated antibacterial and antiviral properties can help prevent the accumulation of harmful bacteria and viruses from forming on the surface of a person’s skin underneath the device itself. 

The material’s breathability is also designed to help mitigate the loss of an accurate signal when a person sweats. Another benefit is the material’s ultra-soft properties, Yan said. 

“Under the microscope, our skin is not flat,” Yan said. “So, an ultra-soft material can form what we call a conformal contact, which is very important for us in order to have a high level of accuracy for our signal recording of the electrical activity of the human heart.” 

Similar devices in existence today typically only monitor the human heart via an ECG, and have limited long-term use, Yan said. Currently the device is a small, wired patch connected to a small data processor that can be attached to a person’s shirt, and researchers hope to one day develop a wireless version. 

The project, “Multifunctional Porous Soft Materials for User-Friendly Skin-Interfaced Bimodal Cardiac Patches with Long-Term Biocompatibility and Antimicrobial Property” is being supported by the National Institutes of Health (1-R01-EB033371-01). 

For more information: https://showme.missouri.edu/schools-colleges/mu-college-of-engineering/ 


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now